Cost-Effectiveness of Continuation Maintenance Pemetrexed After Cisplatin and Pemetrexed Chemotherapy for Advanced Nonsquamous Non–Small-Cell Lung Cancer: Estimates From the Perspective of the Chinese Health Care System
2013 ◽
Vol 35
(1)
◽
pp. 54-65
◽
Keyword(s):
Keyword(s):
Keyword(s):
Keyword(s):
Keyword(s):
Cost–effectiveness of second-line nivolumab for platinum-treated advanced non-small-cell lung cancer
2020 ◽
Vol 9
(18)
◽
pp. 1301-1309
Keyword(s):
The Cost
◽
2021 ◽
pp. 1-13
Keyword(s):
2019 ◽
Vol Volume 11
◽
pp. 9195-9202
◽
Keyword(s):